Friedrich Goetz

Title: Friedrich Goetz: Innovator in Recombinant DNA Technology

Introduction

Friedrich Goetz is a notable inventor based in Tuebingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant DNA-derived proteins. With a total of 5 patents, his work has advanced the understanding and application of thrombolysis and protein production in prokaryotic cells.

Latest Patents

Goetz's latest patents include innovative methods for large-scale production of recombinant DNA-derived tissue plasminogen activator (tPA) and K2S molecules. These inventions focus on producing tPA derivatives in prokaryotic cells, ensuring that the proteins are secreted extracellularly as active and correctly folded entities. His methods utilize a vector that contains DNA coding for tPA or K2S, operably linked to the signal peptide OmpA. Additionally, he has developed methods for large-scale protein production in prokaryotes, which also involve the secretion of heterologous proteins as active and correctly folded proteins.

Career Highlights

Throughout his career, Friedrich Goetz has worked with prominent companies, including Boehringer Ingelheim International GmbH. His expertise in recombinant DNA technology has positioned him as a key figure in the biotechnology sector.

Collaborations

Goetz has collaborated with notable individuals in his field, including Jiradej Manosroi and Aranya Manosroi. These collaborations have further enriched his research and development efforts.

Conclusion

Friedrich Goetz's contributions to biotechnology through his patents and collaborations highlight his role as an innovator in recombinant DNA technology. His work continues to influence the production of therapeutic proteins and advance the field of biotechnology.